BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11763344)

  • 1. Poliovirus persistence in human cells in vitro.
    Colbère-Garapin F; Jacques S; Drillet AS; Pavio N; Couderc T; Blondel B; Pelletier I
    Dev Biol (Basel); 2001; 105():99-104. PubMed ID: 11763344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
    Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures.
    Pelletier I; Duncan G; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
    Duncan G; Pelletier I; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
    Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
    J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells.
    Labadie K; Pelletier I; Saulnier A; Martin J; Colbère-Garapin F
    Virology; 2004 Jan; 318(1):66-78. PubMed ID: 14972536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic cells from CD155-transgenic mice express CD155 and support poliovirus replication ex vivo.
    Freistadt MS; Eberle KE
    Microb Pathog; 2000 Oct; 29(4):203-12. PubMed ID: 10993739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An approach to understanding the mechanisms of poliovirus persistence in infected cells of neural or non-neural origin.
    Colbére-Garapin F; Duncan G; Pavio N; Pelletier I; Petit I
    Clin Diagn Virol; 1998 Apr; 9(2-3):107-13. PubMed ID: 9645992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro interaction of poliovirus with cytoplasmic dynein.
    González Durán E; del Angel RM; Salas Benito JS
    Intervirology; 2007; 50(3):214-8. PubMed ID: 17283448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of poliovirus persistence: key role of capsid determinants during the establishment phase.
    Pelletier I; Duncan G; Pavio N; Colbère-Garapin F
    Cell Mol Life Sci; 1998 Dec; 54(12):1385-402. PubMed ID: 9893712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus and its cellular receptor: a molecular genetic dissection of a virus/receptor affinity interaction.
    Solecki D; Gromeier M; Harber J; Bernhardt G; Wimmer E
    J Mol Recognit; 1998; 11(1-6):2-9. PubMed ID: 10076797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of poliovirus neurovirulence.
    Ohka S; Nomoto A
    Dev Biol (Basel); 2001; 105():51-8. PubMed ID: 11763337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of poliovirus RNA synthesis as a molecular mechanism contributing to viral persistence in the mouse central nervous system.
    Couderc T; Girard S; Pelletier I; Gosselin AS; Destombes J; Thiesson D; Colbère-Garapin F; Blondel B
    Dev Biol (Basel); 2001; 105():225-30. PubMed ID: 11763332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of poliomyelitis: what we don't know.
    Nathanson N
    Adv Virus Res; 2008; 71():1-50. PubMed ID: 18585526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication.
    Freistadt MS; Fleit HB; Wimmer E
    Virology; 1993 Aug; 195(2):798-803. PubMed ID: 8393247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
    J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unstable receptors disappear from cell surface during poliovirus infection.
    Neznanov N; Chumakov KP; Ullrich A; Agol VI; Gudkov AV
    Med Sci Monit; 2002 Oct; 8(10):BR391-6. PubMed ID: 12388911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One hundred years of poliovirus pathogenesis.
    Racaniello VR
    Virology; 2006 Jan; 344(1):9-16. PubMed ID: 16364730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 is not required for poliovirus replication in cultured cells and does not limit replication in monocytes.
    Freistadt MS; Eberle KE
    Virology; 1996 Oct; 224(2):542-7. PubMed ID: 8874515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event.
    Mueller S; Wimmer E; Cello J
    Virus Res; 2005 Aug; 111(2):175-93. PubMed ID: 15885840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.